Coherus Oncology, Inc. Other Non-Current Liabilities
Coherus Oncology, Inc. (CHRS) had Other Non-Current Liabilities of $17.59 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OtherLiabilitiesNoncurrent · last filed 2026-08-05
- 2026-06-30: Other Liabilities, Noncurrent $17.59M.
- 2026-03-31: Other Liabilities, Noncurrent $16.97M.
- 2025-12-31: Other Liabilities, Noncurrent $19.89M; Other Liabilities, Noncurrent as first filed $18.43M.
- 2025-09-30: Other Liabilities, Noncurrent $17.55M.
| Period end | Other Liabilities, Noncurrent | Other Liabilities, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $17.59M 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $16.97M 10-Q · filed 2026-05-11 | |
| 2025-12-31 | $19.89M 10-Q · filed 2026-08-05 | $18.43M 10-K · filed 2026-03-09 |
| 2025-09-30 | $17.55M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $16.73M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $31.29M 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $29.33M 10-K · filed 2026-03-09 | |
| 2024-09-30 | $29.16M 10-Q · filed 2024-11-06 | |
| 2024-06-30 | $27.70M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $2.73M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $3.56M 8-K · filed 2025-11-13 | $12.56M 10-K · filed 2024-03-15 |
| 2023-09-30 | $3.51M 10-Q · filed 2023-11-06 | |
| 2023-06-30 | $102.00K 10-Q · filed 2023-08-02 | |
| 2023-03-31 | $102.00K 10-Q · filed 2023-05-08 | |
| 2022-12-31 | $3.47M 10-K · filed 2024-03-15 | |
| 2022-09-30 | $102.00K 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $102.00K 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $102.00K 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $750.00K 10-K · filed 2023-03-06 | |
| 2021-09-30 | $750.00K 10-Q · filed 2021-11-08 | |
| 2021-06-30 | $751.00K 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $750.00K 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $1.05M 10-K · filed 2022-02-23 | $949.00K 10-K · filed 2021-02-25 |
| 2020-09-30 | $705.00K 10-Q · filed 2020-11-05 | |
| 2019-12-31 | $0.00 10-K · filed 2020-02-27 | |
| 2019-09-30 | $0.00 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $0.00 10-Q · filed 2019-08-05 | |
| 2018-12-31 | $1.65M 10-K · filed 2020-02-27 | |
| 2018-09-30 | $1.75M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $1.86M 10-Q · filed 2018-08-08 | |
| 2018-03-31 | $1.96M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $2.07M 10-K · filed 2019-02-28 | |
| 2017-09-30 | $2.16M 10-Q · filed 2017-11-06 | |
| 2017-06-30 | $2.11M 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $1.93M 10-Q · filed 2017-05-08 | |
| 2016-12-31 | $1.83M 10-K · filed 2018-03-08 | |
| 2016-09-30 | $1.72M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $1.59M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $1.64M 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $1.70M 10-K · filed 2017-03-14 | |
| 2015-09-30 | $1.75M 10-Q · filed 2015-11-10 | |
| 2015-06-30 | $319.00K 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $334.00K 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $347.00K 10-K · filed 2016-02-29 | |
| 2014-09-30 | $130.00K 10-Q · filed 2014-12-15 | |
| 2013-12-31 | $61.00K 10-K · filed 2015-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |